logo-loader
LSE:PRTC NASDAQ:PRTC OTC:PTCHF

PureTech Health

Receive alerts
Market:
LSE
Price
222.50 GBX
Day Change
-1.11%
Market Cap:
£604.35 m
52 weeks high
242.93
52 weeks low
139.00

In brief

PureTech is a clinical-stage biotherapeutics company dedicated to discovering, developing and commercializing highly differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders, among others.